Top Buy
Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Cellectar BioSciences Inc. | 7 | 9 | 0 | 1 | €2.84 | €10.55 | 271.331% |
Affimed N.V. | 8 | 6 | 3 | 0 | €0.55 | €6.54 | 1083.165% |
TG Therapeutics Inc. | 20 | 4 | 3 | 0 | €12.58 | €27.00 | 114.527% |
Immunic Inc. | 6 | 3 | 1 | 3 | €1.15 | €5.48 | 378.760% |
Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €10.87 | €22.78 | 109.621% |
Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.25 | €3.60 | 188.389% |
Chromadex Corp | 10 | 2 | 1 | 0 | €3.22 | €5.76 | 78.770% |
Biogen Inc. | 44 | 2 | 4 | 1 | €195.30 | €294.45 | 50.767% |
Vertex Pharmaceuticals Inc. | 40 | 2 | 5 | 0 | €371.40 | €382.71 | 3.044% |
Codexis Inc. | 4 | 2 | 0 | 0 | €2.48 | €8.35 | 236.738% |
Adverum Biotechnologies Inc. | 4 | 1 | 0 | 0 | €1.38 | €3.70 | 168.304% |
Adaptimmune Therapeutics PLC ADR | 1 | 1 | 0 | 1 | €1.00 | €1.50 | 50.000% |
Dr. Reddy's Laboratories Ltd. ADR | 5 | 1 | 1 | 0 | €69.00 | €73.92 | 7.130% |
Bayer AG | 15 | 1 | 0 | 0 | €27.48 | €50.00 | 81.984% |
Heron Therapeutics Inc. | 9 | 1 | 3 | 0 | €2.29 | €4.57 | 99.381% |
Natural Alternat. | 18 | 1 | 1 | 0 | €5.65 | - | - |
Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.23 | €3.70 | 201.058% |
Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €69.44 | €140.00 | 101.613% |
Regeneron Pharmaceuticals Inc. | 33 | 1 | 6 | 1 | €825.20 | €957.22 | 15.999% |
Stoke Therapeutics Inc | 14 | 1 | 2 | 0 | €10.60 | €21.00 | 98.147% |
Insmed Inc. | 13 | 1 | 3 | 1 | €23.00 | €44.01 | 91.333% |
G1 Therapeutics | 13 | 1 | 1 | 0 | €3.60 | €10.05 | 178.968% |
Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
Evolus Inc | 6 | 1 | 1 | 1 | €10.90 | €20.26 | 85.829% |
Novo Nordisk A/S ADR | 17 | 1 | 3 | 0 | €119.00 | €130.44 | 9.612% |